IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Skin Diseases among School Children – Can Research Lead to Policy and Action?

Editorial, Volume 04 Issue 3 – July to September 2011

Authors

V Mohanan Nair, BSc., MBBS, MPH, FCGP, MHSc (Canada), Deputy Director of Health Services, Director, Kerala State Institute of Health and Family Welfare, Thiruvananthapuram.


Abstract

Schools provide excellent arenas for public health research and interventions. Though public health interventions are often undertaken in schools, serious epidemiologic health research is not very common. Healthcare interventions in schools are largely based on available information, sometimes generated in other parts of the world, and are often general in nature.

In Kerala, one recent development is the revitalization of the School Health Programme under the National Rural Health Mission (NRHM) and this initiative gives ample scope for translating these research findings to policy and action. The package of school health programme offered under NRHM could be elaborated with inclusion of services aimed at detection and management of skin diseases in school children which would go a long way in reducing the morbidity associated with these conditions.

Keywords: Skin diseases, School Health, Health Policy


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician